Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

ClinicalTrials.gov ID: NCT01734928

Public ClinicalTrials.gov record NCT01734928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 2:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide, Bortezomib and Low-Dose Dexamethasone Versus Bortezomib and Low-Dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the efficacy of the combination of pomalidomide, bortezomib and low dose dexamethasone to the combination of bortezomib and low dose dexamethasone in participants with relapsed/refractory multiple myeloma. This study will also assess how safe the combination of pomalidomide, bortezomib and low dose dexamethasone is compared to the combination of bortezomib and low dose dexamethasone.

Study identification

NCT ID
NCT01734928
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Celgene
Industry
Enrollment
559 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 6, 2013
Primary completion
May 8, 2022
Completion
May 12, 2022
Last update posted
Jun 5, 2023

2013 – 2022

United States locations

U.S. sites
92
U.S. states
34
U.S. cities
71
Facility City State ZIP Site status
Southern Cancer Center Mobile Alabama 36608 —
Arizona Oncology Tucson Arizona 85710 —
University of Arizona Cancer Center Tucson Arizona 85724 —
Alta Bates Comprehensive Cancer Center Berkeley California 94704 —
University of California San Francisco Fresno Campus Fresno California 93701 —
Marin Oncology Associates Greenbrae California 94904-2007 —
Moore UCSD Cancer Center La Jolla California 92083 —
USC Norris Comprehensive Cancer Center Los Angeles California 90033 —
Sutter Pacific Medical Foundation Santa Rosa California 95403 —
University of Colorado Cancer Center Aurora Colorado 80045 —
Cancer Center of Central Connecticut Southington Connecticut 06489 —
Local Institution - 153 Southington Connecticut 06489 —
George Washington Medical Center Washington D.C. District of Columbia 20037 —
Lynn Cancer Institute Boca Raton Florida 33486 —
University Cancer Institute Boynton Beach Florida 33426 —
Broward Oncology Associates PA Fort Lauderdale Florida 33308 —
Broward Oncology Assoc. Fort Lauderdale Florida 33316 —
University of Florida Gainesville Florida 32610 —
Alves Domenech Oncology and Hematology Clinic Hollywood Florida 33021 —
Palm Beach Cancer Institute, LLC West Palm Beach Florida 33401 —
Local Institution - 135 Marietta Georgia 30060 —
Northwest Georgia Oncology Centers, PCWilliam S. Gibbons Center Research Institute Marietta Georgia 30060 —
University of Chicago Chicago Illinois 60637-1470 —
Investigative Clinical Research of Indiana, LLC Indianapolis Indiana 46254 —
University of Iowa Iowa City Iowa 52242 —
Western Kentucky Hematology and Oncology Group, PSC Paducah Kentucky 42003 —
Tulane University Medical Center New Orleans Louisiana 70112 —
Cancer Care of Maine Bangor Maine 04401 —
Local Institution - 132 Bangor Maine 04401 —
St. Agnes - Medical Center Baltimore Maryland 21229-5299 —
Center for Cancer and Blood Disorders Bethesda Maryland 20817 —
Local Institution - 125 Bethesda Maryland 20817 —
Medstar Health Research Institute Hyattsville Maryland 20782 —
Local Institution - 299 Boston Massachusetts 02114 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Dana Farber Cancer Institute Boston Massachusetts 02115 —
Local Institution - 100 Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Local Institution - 298 Boston Massachusetts 02215 —
Henry Ford Medical Center - New Center One Detroit Michigan 48202-268 —
Local Institution - 178 Detroit Michigan 48202-268 —
Cancer and Hematology Centers of Western Michigan Grand Rapids Michigan 49546 —
Detroit Clinical Research Center Lansing Michigan 48912 —
Beaumont Cancer Center Royal Oak Michigan 48073 —
Essentia Health Duluth CCOP Duluth Minnesota 55805 —
Metro MN CCOP Saint Louis Park Minnesota 55416 —
Columbia Comprehensive Jefferson City Missouri 65203 —
Kansas City VA Medical Center University of Kansas Medical Center Kansas City Missouri 64128 —
St. John's Clinic Cancerand Hematology - Springfield Springfield Missouri 65804 —
St John's Mercy Medical Center St Louis Missouri 63141 —
Billings Clinic Billings Montana 59102 —
Southeast Nebraska Cancer Center Lincoln Nebraska 68510 —
CarePoint Health Research Institute Jersey City New Jersey 07306 —
Hematology-Oncology Associates of NNJ, P Morristown New Jersey 07960 —
Somerset Hematology-Oncology Associates Somerville New Jersey 08876 —
Mount Sinai Hospital New York New York 10029 —
Stony Brook University Stony Brook New York 11794-7300 —
Local Institution - 186 The Bronx New York 10467 —
Montefiore Medical Center The Bronx New York 10467 —
New York Medical College Valhalla New York 10595 —
Eastern Institute of Medical Sciences Greenville North Carolina 27834 —
Boice-Willis Clinic P.A. Rocky Mount North Carolina 27804 —
Gabrail Cancer Center Research Canton Ohio 44718 —
Local Institution - 111 Canton Ohio 44718 —
MetroHealth Medical Systems Cleveland Ohio 44109 —
Mid Ohio Oncology Hematology Inc Columbus Ohio 43219 —
University of Toledo Medical Center Toledo Ohio 43614 —
Providence Portland Medical Center Portland Oregon 97213 —
Med Univ of South Carolina Charleston South Carolina 29425 —
Spartanburg Regional Healthcare System - Gibbs Cancer Center & Research Institute Spartanburg South Carolina 29303 —
Avera Research Institute Sioux Falls South Dakota 57105 —
Local Institution - 167 Watertown South Dakota 57201 —
Prairie Lakes Health Care System Watertown South Dakota 57201 —
University of Tennessee Medical Center - Cancer Institute Knoxville Tennessee 37885 —
Vanderbilt University Medical Center Nashville Tennessee 37232-5505 —
Local Institution - 114 Dallas Texas 75390 —
UT Southwestern Medical Center Dallas Texas 75390 —
Brooke Army Medical Center Francis Street Medical Center Fort Sam Houston Texas 78235-8200 —
Local Institution - 103 Fort Sam Houston Texas 78235-8200 —
Local Institution - 130 Houston Texas 77090 —
Northwest Cancer Center Houston Texas 77090 —
Joe Arrington Cancer Research and Treatment Center Lubbock Texas 79410 —
Utah Cancer Specialist Salt Lake City Utah 84106 —
Huntsman Cancer Institute at the University of Utah Salt Lake City Utah 84112 —
Swedish Cancer Inst Seattle Washington 98104 —
Medical Oncology Associates Spokane Washington 99208 —
Wenatchee Valley Hospital and Clinics Wenatchee Washington 98801 —
Local Institution - 139 Morgantown West Virginia 25606 —
West Virginia University CTRU Morgantown West Virginia 25606 —
University of Wisconsin Madison Wisconsin 53792 —
Local Institution - 136 Milwaukee Wisconsin 53226 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 229 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01734928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 5, 2023 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01734928 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →